ClinVar Miner

Submissions for variant NM_022124.6(CDH23):c.2341G>A (p.Ala781Thr) (rs375918283)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000155046 SCV000204730 uncertain significance not specified 2013-12-05 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The Ala781Thr varia nt in CDH23 has not been previously reported in individuals with hearing loss, b ut was identified in 0.04% (2/4214) of African American chromosomes by the NHLBI Exome Sequencing Project (; rs37591828). Compu tational analyses (biochemical amino acid properties, conservation, AlignGVGD, P olyPhen2, and SIFT) suggest that the Ala781Thr variant may not impact the protei n, though this information is not predictive enough to rule out pathogenicity. I n summary, the clinical significance of this variant cannot be determined with c ertainty; however based upon the arguments described above, we would lean toward s a more likely benign role.
Invitae RCV001051031 SCV001215164 uncertain significance not provided 2020-09-09 criteria provided, single submitter clinical testing This sequence change replaces alanine with threonine at codon 781 of the CDH23 protein (p.Ala781Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs375918283, ExAC 0.1%). This variant has not been reported in the literature in individuals with CDH23-related conditions. ClinVar contains an entry for this variant (Variation ID: 178302). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: Deleterious; PolyPhen-2: Not Available; Align-GVGD: Class C5). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. 5
Natera, Inc. RCV001275940 SCV001461620 uncertain significance Usher syndrome type 1 2020-01-24 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.